CONTEXT: Report of one poster presentation and four abstracts derived from Synapse’ RWD capabilities at ASCO 2021. Further evidence of RWD becoming an increasingly valuable tool for oncology research.
IMPACT: Medium
READ TIME: 5 mins
Quality Level Mean [1 – 10]: 8
1. “This approach to care would not even be imaginable without the tremendous strides that are being made in the use of real-world data to inform patient care,” said Mike Thompson, MD, PhD, FASCO, co-director of oncology precision medicine at Aurora Health Care, ASCO board member and study co-author.”
2. “The studies underscore the potential for real-world data to advance cancer care, while showcasing Syapse’ unparalleled data analytics and insights capabilities.”
3. “The theme of this year’s Meeting is ‘Equity: Every Patient.”
4. ““ The following are a summary of the published, and presented, abstracts using RWD from the Syapse Learning Health NetworkTM:”
5. “Poster presentation:”
Source URL: https://finance.yahoo.com/news/syapse-announces-real-world-data-130000628.html